File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/bju.13768
- Scopus: eid_2-s2.0-85057395147
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Conference Paper: Ten-year experience on retransurethral resection of non-muscle-invasive bladder cancer. Are we doing on the right patients?
Title | Ten-year experience on retransurethral resection of non-muscle-invasive bladder cancer. Are we doing on the right patients? |
---|---|
Authors | |
Issue Date | 2017 |
Publisher | Wiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.bjui.org/ |
Citation | 22nd Annual Scientific Meeting of the Hong Kong Urological Association, Hong Kong, 20 November 2016. In BJU International, 2017, v. 119 n. suppl. 3, p. 9 How to Cite? |
Abstract | Objective: To examine the outcomes ofre-transurethral resection (re-TUR) inpatients with non-muscle invasive bladdercancer (NMIBC).
Patients and Methods: We retrospectivelyreviewed data from Jan 2004 to Dec 2014in Queen Mary and Tung Wah Hospitals.One-hundred-and-eight patients under-went re-TUR for NMIBC. Exclusion crite-ria included histology other thantransitional cell carcinoma (TCC), historyof upper tract TCC and macroscopicincomplete initial resection.Results: Fifty-five patients (51%) had T1tumor and 93 patients (86.1%) had high-grade (HG) disease on the initial resection.Muscularis propria was included in 38patients (35.2%) on the initial resection.After re-TUR, 8 patients (7.4%) hadupstaged to muscle-invasive disease while6 patients (5.6%) still had T1HG tumor inthe resection specimen. This resulted in achange of management to radical treat-ment in ten percent of patients. Allpatients with upstaged muscle-invasivedisease after re-TUR had HG tumor,87.5% had tumor larger than 3 cm and75% had T1 tumor on the initial resection.All 15 patients with low grade disease onthe initial resection did not show anyupstaging after re-TUR.Conclusion: Re-TUR remains an impor-tant treatment strategy to detect upstagingin bladder cancer especially in thosepatients with T1HG disease and withtumor larger than 3 cm. |
Description | Abstract |
Persistent Identifier | http://hdl.handle.net/10722/241668 |
ISSN | 2023 Impact Factor: 3.7 2023 SCImago Journal Rankings: 1.337 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, JKW | - |
dc.contributor.author | Lai, TCT | - |
dc.contributor.author | Tsnag, CF | - |
dc.contributor.author | Ho, SHB | - |
dc.contributor.author | Ng, ATL | - |
dc.contributor.author | Ma, WK | - |
dc.contributor.author | Tsu, HLJ | - |
dc.contributor.author | Yiu, MK | - |
dc.date.accessioned | 2017-06-20T01:46:55Z | - |
dc.date.available | 2017-06-20T01:46:55Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | 22nd Annual Scientific Meeting of the Hong Kong Urological Association, Hong Kong, 20 November 2016. In BJU International, 2017, v. 119 n. suppl. 3, p. 9 | - |
dc.identifier.issn | 1464-4096 | - |
dc.identifier.uri | http://hdl.handle.net/10722/241668 | - |
dc.description | Abstract | - |
dc.description.abstract | Objective: To examine the outcomes ofre-transurethral resection (re-TUR) inpatients with non-muscle invasive bladdercancer (NMIBC). Patients and Methods: We retrospectivelyreviewed data from Jan 2004 to Dec 2014in Queen Mary and Tung Wah Hospitals.One-hundred-and-eight patients under-went re-TUR for NMIBC. Exclusion crite-ria included histology other thantransitional cell carcinoma (TCC), historyof upper tract TCC and macroscopicincomplete initial resection.Results: Fifty-five patients (51%) had T1tumor and 93 patients (86.1%) had high-grade (HG) disease on the initial resection.Muscularis propria was included in 38patients (35.2%) on the initial resection.After re-TUR, 8 patients (7.4%) hadupstaged to muscle-invasive disease while6 patients (5.6%) still had T1HG tumor inthe resection specimen. This resulted in achange of management to radical treat-ment in ten percent of patients. Allpatients with upstaged muscle-invasivedisease after re-TUR had HG tumor,87.5% had tumor larger than 3 cm and75% had T1 tumor on the initial resection.All 15 patients with low grade disease onthe initial resection did not show anyupstaging after re-TUR.Conclusion: Re-TUR remains an impor-tant treatment strategy to detect upstagingin bladder cancer especially in thosepatients with T1HG disease and withtumor larger than 3 cm. | - |
dc.language | eng | - |
dc.publisher | Wiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.bjui.org/ | - |
dc.relation.ispartof | BJU International | - |
dc.rights | Preprint This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article]. Authors are not required to remove preprints posted prior to acceptance of the submitted version. Postprint This is the accepted version of the following article: [full citation], which has been published in final form at [Link to final article]. | - |
dc.title | Ten-year experience on retransurethral resection of non-muscle-invasive bladder cancer. Are we doing on the right patients? | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Ho, SHB: hobrian@hku.hk | - |
dc.identifier.email | Ma, WK: mwk054@hku.hk | - |
dc.identifier.email | Tsu, HLJ: jamestsu@hku.hk | - |
dc.identifier.email | Yiu, MK: pmkyiu@hku.hk | - |
dc.identifier.doi | 10.1111/bju.13768 | - |
dc.identifier.scopus | eid_2-s2.0-85057395147 | - |
dc.identifier.hkuros | 272638 | - |
dc.identifier.volume | 119 | - |
dc.identifier.issue | suppl. 3 | - |
dc.identifier.spage | 9 | - |
dc.identifier.epage | 9 | - |
dc.publisher.place | United Kingdom | - |
dc.customcontrol.immutable | csl 170718 | - |
dc.identifier.issnl | 1464-4096 | - |